The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ICML 2019 | Moving towards chemo-free regimens in CLL
Michael Hallek
• 19 Jun 2019
Michael Hallek, MD, PhD, University of Cologne, Cologne, Germany, discusses the emergence of chemotherapy-free regimens in chronic lymphocytic leukemia (CLL), highlighting the situtations where this approach wouldn’t be used. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.
